NCT00697788View on ClinicalTrials.gov

Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 16, 2007

Primary Completion Date

December 30, 2008

Study Completion Date

December 30, 2008

Conditions
BurnsSedation
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine bolus 1 ug/kg over 10 minutes, followed by ascending infusion as follows: Dexmedetomidine \[in ug/kg/hr\], each for 15 minutes: 0.7, 1.0, 1.3, 1.6, 1.9, 2.2, 2.5.

Trial Locations (1)

02114

Shriners Burn Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00697788 - Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients | Biotech Hunter | Biotech Hunter